000 04112naa a22004937i 4500
001 UMUN-OA-20261005-PH-050
003 local
005 20261005174915.0
006 m o d
007 cr||||||||||||
008 261005s2014 xx o u000 0 eng d
024 7 _a10.3389/fimmu.2014.00446
_2doi
035 _a(local)EuropePMC:PMC4165321
040 _alocal
_beng
_clocal
041 0 _aeng
100 0 _aStefan Niewiesk
_eauthor.
245 1 0 _aMaternal antibodies: clinical significance, mechanism of interference with immune responses, and possible vaccination strategies. /
_cStefan Niewiesk.
264 1 _a[Place of publication not identified] :
_bFrontiers Media SA,
_c2014.
300 _a1 online resource (1 article).
336 _atext
_btxt
_2rdacontent
337 _acomputer
_bc
_2rdamedia
338 _aonline resource
_bcr
_2rdacarrier
500 _aPublication type: Review article.
500 _aLinked open-access copy: published version.
506 0 _aOpen access; no subscription required for the linked open-access version.
_fUnrestricted online access
_2star
520 3 _aNeonates have an immature immune system, which cannot adequately protect against infectious diseases. Early in life, immune protection is accomplished by maternal antibodies transferred from mother to offspring. However, decaying maternal antibodies inhibit vaccination as is exemplified by the inhibition of seroconversion after measles vaccination. This phenomenon has been described in both human and veterinary medicine and is independent of the type of vaccine being used. This review will discuss the use of animal models for vaccine research. I will review clinical solutions for inhibition of vaccination by maternal antibodies, and the testing and development of potentially effective vaccines. These are based on new mechanistic insight about the inhibitory mechanism of maternal antibodies. Maternal antibodies inhibit the generation of antibodies whereas the T cell response is usually unaffected. B cell inhibition is mediated through a cross-link between B cell receptor (BCR) with the Fcγ-receptor IIB by a vaccine-antibody complex. In animal experiments, this inhibition can be partially overcome by injection of a vaccine-specific monoclonal IgM antibody. IgM stimulates the B cell directly through cross-linking the BCR via complement protein C3d and antigen to the complement receptor 2 (CR2) signaling complex. In addition, it was shown that interferon alpha binds to the CD21 chain of CR2 as well as the interferon receptor and that this dual receptor usage drives B cell responses in the presence of maternal antibodies. In lieu of immunizing the infant, the concept of maternal immunization as a strategy to protect neonates has been proposed. This approach would still not solve the question of how to immunize in the presence of maternal antibodies but would defer the time of infection to an age where infection might not have such a detrimental outcome as in neonates. I will review successful examples and potential challenges of implementing this concept.
540 _aCreative Commons Attribution. See the linked licence for the applicable terms.
_uhttp://creativecommons.org/licenses/by/4.0/
546 _aIn English.
588 0 _aDescription generated from Europe PMC bibliographic metadata retrieved on 5 October 2026; full text linked from the source.
590 _aCourse allocation: B. Sc. Public Health.
650 4 _amaternal antibody
650 4 _aB Cell Receptor
650 4 _aMaternal Immunization
650 4 _aFcγriib
650 4 _aCotton Rat
653 _aB. Sc. Public Health
653 _aUMUN open access collection
653 _avaccination
655 4 _aReview articles.
773 0 _tFrontiers in immunology
_gVol. 5, (2014), pages/article 446
_x1664-3224
856 4 0 _uhttps://europepmc.org/articles/PMC4165321
_yRead open-access publication
_zOpen access.
_70
884 _aCourse selection and automated MARC21 enrichment from Europe PMC metadata.
_g20261005
_khttps://europepmc.org/articles/PMC4165321
_qlocal
942 _n0
999 _c1322
_d1322